• EGTA in Calcium Signaling Assays: Applied Workflows & Soluti

  2026-07-27

  EGTA (egtzic acid) is a selective calcium chelator that enables precise modulation of calcium-dependent pathways in neurodegeneration and vascular inflammation studies. This article presents actionable protocols, troubleshooting strategies, and key innovations supported by recent findings on endothelial inflammation and atherosclerosis.

• Diuron (SKU C6731): Data-Driven Solutions for Toxicology Ass

  2026-07-27

  This article guides biomedical researchers and lab technicians through scenario-driven laboratory challenges involving Diuron (SKU C6731). Drawing on peer-reviewed evidence and real-world workflow needs, it demonstrates how high-purity Diuron from APExBIO supports reproducibility and mechanistic insight in cell viability, proliferation, and environmental toxicology assays.

• KPNB1-ATF4-BNIP3 Axis Drives Mitophagy in DPSC Differentiati

  2026-07-26

  Zhang et al. present a mechanistic study showing that the KPNB1-ATF4-BNIP3 signaling axis regulates BNIP3-dependent mitophagy, which is essential for odontoblastic differentiation of dental pulp stem cells (DPSCs). Their findings reveal new molecular targets for dental tissue regeneration strategies and provide a detailed workflow for dissecting mitophagy-driven differentiation.

• iTBS Enhances Motor Function and Modulates Pathology in SCA3

  2026-07-25

  This study demonstrates that intermittent theta-burst stimulation (iTBS) significantly improves motor coordination and reduces neuroinflammation in a mouse model of spinocerebellar ataxia type 3 (SCA3/MJD). The findings suggest paradigm-specific benefits of iTBS over continuous TBS, with implications for non-invasive therapeutic strategies.

• Dihydroethidium: Mechanistic Leverage for Translational Redo

  2026-07-24

  This thought-leadership article dissects the mechanistic and translational potential of Dihydroethidium (DHE, hydroethidine) as a high-fidelity probe for superoxide detection. Integrating fresh mechanistic insights from vascular remodeling and oxidative stress research, we highlight APExBIO’s DHE as an essential tool for researchers targeting redox-driven pathology in pulmonary, cardiovascular, and related disease models. The discussion bridges protocol best practices, competitive landscape, and future outlook, providing strategic guidance for translational scientists.

• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-07-24

  This study reveals that targeted degradation of RNA Polymerase II (Pol II), rather than global transcriptional inhibition, activates a distinct cell death pathway. The findings redefine the molecular mechanisms of apoptosis induction in tumor cells and have practical implications for refining apoptosis assays and developing targeted cancer therapeutics.

• Ozone Enhances Macrophage Efferocytosis to Alleviate Neuropa

  2026-07-23

  This study uncovers how ozone therapy promotes macrophage clearance of apoptotic cells and reduces neuropathic pain via the AMPK/Gas6-MerTK/SOCS3 pathway. The findings highlight a mechanistically distinct strategy for modulating neuroinflammation and suggest new directions for targeted pain therapy.

• ER Stress Impairs Intestinal Stem Cells via GRP78/ATF6/CHOP

  2026-07-23

  This study by Fan et al. demonstrates that endoplasmic reticulum stress (ERS), induced by tunicamycin, disrupts intestinal stem cell (ISC) maintenance and differentiation via the GRP78/ATF6/CHOP signaling axis. The findings highlight the mechanistic link between ERS and intestinal barrier dysfunction, providing a molecular basis for future investigations into gastrointestinal disease pathogenesis.

• Bazedoxifene: Molecular Precision for Bone Density Research

  2026-07-22

  Explore the molecular, biophysical, and translational dimensions of Bazedoxifene as a selective estrogen receptor modulator. This in-depth article uniquely analyzes its role in bone mineral density enhancement, setting it apart from practical workflow guides.

• Epoxomicin (SKU A2606): Reliable Proteasome Inhibitor for Ce

  2026-07-22

  This article provides an evidence-based guide to applying Epoxomicin (SKU A2606) for cell viability, proliferation, and cytotoxicity assays. Scenario-driven Q&A blocks address common experimental challenges, highlight protocol optimization, and clarify vendor reliability, ensuring researchers achieve reproducible, sensitive ubiquitin-proteasome pathway data.

• VEGFC–VEGFR-3 Axis in NASH-Related Fibrosis: Insights from I

  2026-07-21

  This study demonstrates that inhibition of the VEGFC–VEGFR-3 signaling axis, either pharmacologically with SAR131675 or via hepatocyte-specific Vegfc knockout, alleviates hepatic fibrosis in high-fat diet-induced NASH models. The findings highlight the regulatory role of hepatocyte-derived VEGFC on macrophage migration and phenotype, offering mechanistic insight and new directions for anti-fibrotic and anti-lymphangiogenic research.

• IGFBP2-THBS1 Axis: Next-Gen Strategy for Recombinant GH Rese

  2026-07-21

  This thought-leadership article dissects the mechanistic advances and translational strategies emerging from recent discoveries on the IGFBP2-THBS1-IGF-1 axis in growth hormone biology. With a focus on APExBIO’s Recombinant Human Growth Hormone (GH), we explore how these insights empower translational researchers to design more predictive, clinically relevant studies, and discuss protocol, competitive, and strategic guidance for leveraging recombinant somatotropin in next-generation pituitary growth hormone research.

• Epalrestat: Aldose Reductase Inhibitor for Polyol Pathway Re

  2026-07-20

  Epalrestat is a high-purity aldose reductase inhibitor developed for precise modulation of the polyol pathway in diabetic complication and oxidative stress research. It is validated for use in mechanistic studies targeting metabolic dysregulation, including cancer metabolism and neurodegeneration. Recent literature supports its role in polyol pathway inhibition, which is increasingly relevant in cancer biology.

• PPT (Propyl Pyrazole Triol): Precision Tools for ERα Network

  2026-07-20

  Explore how PPT (Propyl Pyrazole Triol), a potent selective ERα agonist, is revolutionizing estrogen receptor signaling research. This article reveals advanced assay strategies and novel biomarker implications, offering unique insights for translational scientists.

• Applied Workflows with Z-VAD-FMK: Advancing Apoptosis Inhibi

  2026-07-19

  Discover how Z-VAD-FMK transforms apoptosis research by providing robust, irreversible pan-caspase inhibition across cell models. This article delivers actionable protocols, troubleshooting guidance, and insights from the latest cross-talk studies on regulated cell death, positioning APExBIO's Z-VAD-FMK as an essential tool for dissecting apoptotic and non-apoptotic pathways.

16588 records 1/1106 page Next 12345 下5页 Last page